FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alexander Turpie

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Ajay K Kakkar; Gloria Kayani; Gregory Y H Lip; Lorenzo G Mantovani; Frank Misselwitz; Iris Mueller; Sophie Rushton-Smith; Alexander G G Turpie; Martin van Eickels; Freek W A Verheugt; Peter Wilkinson; Jean-Pierre Bassand; David A Fitzmaurice; Samuel Z Goldhaber; Shinya Goto; Sylvia Haas; Werner Hacke
Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry.
Alexander G G Turpie; Roger D Yusen; Min Chen; Russell D Hull; Manuel Monreal; Meyer-Michel Samama; Sebastian M Schellong; Victor F Tapson
Venous thromboembolism risk in ischemic stroke patients receiving extended-duration enoxaparin prophylaxis: results from the EXCLAIM study.
Francesco Dentali; Gregory Y H Lip; Nicoletta Riva; Alexander G G Turpie; Mark Crowther; Walter Ageno
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alexander Turpie (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ajay K Kakkar; Gloria Kayani; Gregory Y H Lip; Lorenzo G Mantovani; Frank Misselwitz; Iris Mueller; Sophie Rushton-Smith; Alexander G G Turpie; Martin van Eickels; Freek W A Verheugt; Peter Wilkinson; Jean-Pierre Bassand; David A Fitzmaurice; Samuel Z Goldhaber; Shinya Goto; Sylvia Haas; Werner Hacke
Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry.
PloS one 2013;8(5):e63479.
2013: Alexander G G Turpie; Roger D Yusen; Min Chen; Russell D Hull; Manuel Monreal; Meyer-Michel Samama; Sebastian M Schellong; Victor F Tapson
Venous thromboembolism risk in ischemic stroke patients receiving extended-duration enoxaparin prophylaxis: results from the EXCLAIM study.
Stroke; a journal of cerebral circulation 2013;44(1):249-51.
2012: Francesco Dentali; Gregory Y H Lip; Nicoletta Riva; Alexander G G Turpie; Mark Crowther; Walter Ageno
Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.
Circulation 2012;126(20):2381-91.
2012: Giancarlo Agnelli; Umesh Chaudhari; William Fisher; Daniel J George; Ajay K Kakkar; Michael R Lassen; Francesca Lawson; Patrick Mismetti; Patrick Mouret; Alexander G G Turpie
Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.
The New England journal of medicine 2012;366(7):601-9.
2011: Alex C Spyropoulos; Victor Tapson; Alexander G G Turpie; Rainer B Zotz; Frederick A Anderson; Jean-François Bergmann; Beng H Chong; Herve Decousus; Gordon Fitzgerald; James B Froehlich; Ajay K Kakkar; Geno J Merli; Manuel Monreal; Mashio Nakamura; Ricardo Pavanello; Mario Pini; Franco Piovella; Frederick A Spencer
Predictive and associative models to identify hospitalized medical patients at risk for VTE.
Chest 2011;140(3):706-14.
2011: Alexander G G Turpie
Response to "Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban".
Journal of clinical pharmacology 2011;51(7):1122-3.
2011: Alan D Bell; Raymond Cartier; Wee-Shian Chan; James D Douketis; Anil Gupta; Maria E Kraw; Thomas F Lindsay; Michael P Love; Neesh Pannu; Rémi Rabasa-Lhoret; André Roussin; Ashfaq Shuaib; Jean-François Tanguay; Philip Teal; Pierre Théroux; Alexander G G Turpie; Robert C Welsh
The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines.
The Canadian journal of cardiology 2011;27 Suppl A():S1-59.
2011: Neil A Goldenberg; Alex C Spyropoulos; Jonathan L Halperin; Craig M Kessler; Sam Schulman; Alexander G G Turpie; Allan Michael Skene; Neal R Cutler; William R Hiatt
Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model.
Blood 2011;117(7):2089-92.
2011: Hervé Decousus; Victor F Tapson; Jean-François Bergmann; Beng H Chong; James B Froehlich; Ajay K Kakkar; Geno Merli; Manuel Monreal; Mashio Nakamura; Ricardo Pavanello; Mario Pini; Franco Piovella; Frederick A Spencer; Alex C Spyropoulos; Alexander G G Turpie; Rainer B Zotz; Gordon Fitzgerald; Frederick A Anderson
Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators.
Chest 2011;139(1):69-79.
2010: Russell D Hull; Sebastian M Schellong; Victor F Tapson; Manuel Monreal; Meyer-Michel Samama; Philippe Nicol; Eric Vicaut; Alexander G G Turpie; Roger D Yusen
Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial.
Annals of internal medicine 2010;153(1):8-18.
2009: Ganesan Karthikeyan; John W Eikelboom; Alexander G G Turpie; Jack Hirsh
Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism?
British journal of haematology 2009;146(2):142-9.
2009: Alexander G G Turpie; Michael R Lassen; Bruce L Davidson; Kenneth A Bauer; Michael Gent; Louis M Kwong; Fred D Cushner; Paul A Lotke; Scott Darrell Berkowitz; Tiemo J Bandel; Alice Benson; Frank Misselwitz; William D Fisher
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.
Lancet 2009;373(9676):1673-80.
2009: Alexander G G Turpie; Anthonie W A Lensing; Takeshi Fuji; Duane A Boyle
Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009;20(2):114-21.
2009: Alexander G G Turpie; Kenneth A Bauer; Bruce L Davidson; William D Fisher; Michael Gent; Michael H Huo; Uma Sinha; Daniel D Gretler
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
Thrombosis and haemostasis 2009;101(1):68-76.
2008: Clive Kearon; Jim A Julian; Michael J Kovacs; David R Anderson; Philip Wells; Betsy MacKinnon; Jeffrey I Weitz; Mark A Crowther; Sean Dolan; Alexander G G Turpie; William Geerts; Susan Solymoss; Paul van Nguyen; Christine Demers; Susan R Kahn; Jeannine Kassis; Marc A Rodger; Julie Hambleton; Michael Gent; Jeffrey S Ginsberg
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.
Blood 2008;112(12):4432-6.
2008: Alex C Spyropoulos; Alexander G G Turpie; Andrew S Dunn; Scott S Kaatz; James Douketis; Alan Jacobson; Hans Petersen
Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry).
The American journal of cardiology 2008;102(7):883-9.
2008: Michael R Lassen; Walter Ageno; Lars C Borris; Jay R Lieberman; Nadia Rosencher; Tiemo J Bandel; Frank Misselwitz; Alexander G G Turpie
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
The New England journal of medicine 2008;358(26):2776-86.
2008: William D Fisher; Alexander G G Turpie
Outpatient thromboprophylaxis after hip or knee surgery: discrepancies and concerns.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2008;178(12):1571-2.
2008: Jacques LeLorier; Alan Bell; David J Bougher; Jafna L Cox; Alexander G G Turpie
Drug reimbursement policies in Canada--need for improved access to critical therapies.
The Annals of pharmacotherapy 2008;42(6):869-73.
2008: Michael R Lassen; Ola Dahl; Patrick Mismetti; Dirk Zielske; Alexander G G Turpie
SR123781A: a new once-daily synthetic oligosaccharide anticoagulant for thromboprophylaxis after total hip replacement surgery: the DRIVE (Dose Ranging Study in Elective Total Hip Replacement Surgery) study.
Journal of the American College of Cardiology 2008;51(15):1498-504.
2008: Alexander G G Turpie
The top 4 advances in antithrombotic care in the last year.
Thrombosis research 2008;123 Suppl 1():S2-6.
2008: Wolfgang Mueck; Bengt I Eriksson; Kenneth A Bauer; Lars Borris; Ola E Dahl; William D Fisher; Michael Gent; Sylvia Haas; Menno V Huisman; Ajay K Kakkar; Peter Kälebo; Louis M Kwong; Frank Misselwitz; Alexander G G Turpie
Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery.
Clinical pharmacokinetics 2008;47(3):203-16.
2008: Alexander G G Turpie
New oral anticoagulants in atrial fibrillation.
European heart journal 2008;29(2):155-65.
2007: A S Dunn; Alex C Spyropoulos; Alexander G G Turpie
Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT).
Journal of thrombosis and haemostasis : JTH 2007;5(11):2211-8.
2007: Alexander G G Turpie; Kenneth A Bauer; J A Caprini; PC Comp; Michael Gent; J E Muntz
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison.
Journal of thrombosis and haemostasis : JTH 2007;5(9):1854-61.
2007: Victor F Tapson; Hervé Decousus; Mario Pini; Beng H Chong; James B Froehlich; Manuel Monreal; Alex C Spyropoulos; Geno Merli; Rainer B Zotz; Jean-François Bergmann; Ricardo Pavanello; Alexander G G Turpie; Mashio Nakamura; Franco Piovella; Ajay K Kakkar; Frederick A Spencer; Gordon Fitzgerald; Frederick A Anderson
Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.
Chest 2007;132(3):936-45.
2007: Bengt I Eriksson; Alexander G G Turpie; Michael R Lassen; Martin H Prins; Giancarlo Agnelli; Peter Kälebo; M L Gaillard; L Meems
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery.
Journal of thrombosis and haemostasis : JTH 2007;5(8):1660-5.
2007: Richard H Hunt; Denis Choquette; Brian N Craig; Carlo De Angelis; Flavio Habal; Gordon Fulthorpe; John I Stewart; Alexander G G Turpie; Paul Davis
Approach to managing musculoskeletal pain: acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs?
Canadian family physician Médecin de famille canadien 2007;53(7):1177-84.
2007: Nikola Sprigg; Laura J Gray; Philip Bath; Ewa Lindenstrøm; Gudrun Boysen; Peter Paul De Deyn; Pal Friis; Didier LEYS; Reijo Marttila; Jan-Edwin Olsson; Desmond O'Neill; E Bernd Ringelstein; Jan-Jacob van der Sande; Alexander G G Turpie
Early recovery and functional outcome are related with causal stroke subtype: data from the tinzaparin in acute ischemic stroke trial.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2007;16(4):180-4.
2007: Sebastian M Schellong; Jan Beyer; Ajay K Kakkar; Kai Halbritter; Bengt I Eriksson; Alexander G G Turpie; Frank Misselwitz; Peter Kälebo
Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study.
Journal of thrombosis and haemostasis : JTH 2007;5(7):1431-7.
2007: William D Fisher; Bengt I Eriksson; Kenneth A Bauer; Lars C Borris; Ola E Dahl; Michael Gent; Sylvia Haas; Martin Homering; Menno V Huisman; Ajay K Kakkar; Peter Kälebo; Louis M Kwong; Frank Misselwitz; Alexander G G Turpie
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
Thrombosis and haemostasis 2007;97(6):931-7.
2007: Alexander G G Turpie
Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(6):1238-47.
2007: Alexander T Cohen; Alexander G G Turpie; Alain Leizorovicz; Carl-Gustav Olsson; Paul T Vaitkus; Samuel Z Goldhaber
Thromboprophylaxis with dalteparin in medical patients: which patients benefit?
Vascular medicine (London, England) 2007;12(2):123-7.
2007: Nikola Sprigg; Laura J Gray; Philip Bath; Ewa Lindenstrøm; Gudrun Boysen; Peter Paul De Deyn; Pal Friis; Didier LEYS; Reijo Marttila; Jan-Edwin Olsson; Desmond O'Neill; E Bernd Ringelstein; Jan-Jacob van der Sande; Alexander G G Turpie
Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial' (TAIST).
Journal of the neurological sciences 2007;254(1-2):54-9.
2007: Martin J O'Donnell; Clive Kearon; Judy Johnson; Marlene Robinson; Michelle Zondag; Irene Turpie; Alexander G G Turpie
Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin.
Annals of internal medicine 2007;146(3):184-7.
2007: Alexander G G Turpie
Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy?
Journal of thrombosis and haemostasis : JTH 2007;5(1):5-11.
2007: Susan R Kahn; Akbar Panju; William Geerts; Graham F Pineo; Louis Desjardins; Alexander G G Turpie; Stanislav Glezer; Lehana Thabane; Rolf J Sebaldt
Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
Thrombosis research 2007;119(2):145-55.
2006: Alexander G G Turpie
Burden of disease: medical and economic impact of acute coronary syndromes.
The American journal of managed care 2006;12(16 Suppl):S430-4.
2006: Alexander G G Turpie; Alain Leizorovicz
Prevention of venous thromboembolism in medically ill patients: a clinical update.
Postgraduate medical journal 2006;82(974):806-9.
2006: Clive Kearon; Jeffrey S Ginsberg; Jim A Julian; James D Douketis; Susan Solymoss; Paul Ockelford; Sharon Jackson; Alexander G G Turpie; Betsy MacKinnon; Jack Hirsh; Michael Gent
Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.
JAMA : the journal of the American Medical Association 2006;296(8):935-42.
2006: Russell D Hull; Sebastian M Schellong; Victor F Tapson; Manuel Monreal; Meyer M Samama; Alexander G G Turpie; Peter Wildgoose; Roger D Yusen
Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.
Journal of thrombosis and thrombolysis 2006;22(1):31-8.
2006: Clive Kearon; Jeffrey S Ginsberg; James D Douketis; Alexander G G Turpie; Shannon M Bates; Agnes Y Y Lee; Mark A Crowther; Jeffrey I Weitz; Patrick Brill-Edwards; Philip Wells; David R Anderson; Michael J Kovacs; Lori-Ann Linkins; Jim A Julian; Laura Bonilla; Michael Gent
An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial.
Annals of internal medicine 2006;144(11):812-21.
2006: Alex C Spyropoulos; Alexander G G Turpie; A S Dunn; J Spandorfer; J Douketis; A Jacobson; Floyd J Frost
Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.
Journal of thrombosis and haemostasis : JTH 2006;4(6):1246-52.
2006: Laura J Gray; Nikola Sprigg; Philip Bath; P Sørensen; Ewa Lindenstrøm; Gudrun Boysen; Peter Paul De Deyn; Pal Friis; Didier LEYS; Reijo Marttila; Jan-Edwin Olsson; Desmond O'Neill; Bernd Ringelstein; Jan-Jacob van der Sande; Alexander G G Turpie
Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST).
Journal of neurology, neurosurgery, and psychiatry 2006;77(3):327-33.
2006: Alexander T Cohen; Bruce L Davidson; Alexander Gallus; Michael R Lassen; Martin H Prins; Witold Tomkowski; Alexander G G Turpie; Jan F M Egberts; Anthonie W A Lensing
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.
BMJ (Clinical research ed.) 2006;332(7537):325-9.
2006: Alexander G G Turpie
Fondaparinux in the management of patients with ST-elevation acute myocardial infarction.
Vascular health and risk management 2006;2(4):371-8.
2006: Clifford W Colwell; Lewis M Kwong; Alexander G G Turpie; Bruce L Davidson
Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery.
The Journal of arthroplasty 2006;21(1):36-45.
2006: Madhu K Natarajan; James L Velianou; Alexander G G Turpie; Shamir R Mehta; Dominic Raco; David M Goodhart; Rizwan Afzal; Jeffrey S Ginsberg
A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions.
American heart journal 2006;151(1):175.
2005: John W Eikelboom; Daniel J Quinlan; Shamir R Mehta; Alexander G G Turpie; Ian B Menown; Salim Yusuf
Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
Circulation 2005;112(25):3855-67.
2005: Franco Piovella; C-J Wang; H Lu; K Lee; L H Lee; W C Lee; Alexander G G Turpie; Alexander Gallus; A Planès; R Passera; A Rouillon
Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography.
Journal of thrombosis and haemostasis : JTH 2005;3(12):2664-70.
2005: Alexander G G Turpie; William D Fisher; K A Bauer; L M Kwong; M W Irwin; Peter Kälebo; Frank Misselwitz; Michael Gent
BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study.
Journal of thrombosis and haemostasis : JTH 2005;3(11):2479-86.
2005: Alexander T Cohen; Raza Alikhan; Juan I Arcelus; Jean-François Bergmann; Sylvia Haas; Geno Merli; Alex C Spyropoulos; Victor F Tapson; Alexander G G Turpie
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.
Thrombosis and haemostasis 2005;94(4):750-9.
2005: Beth L Abramson; Vic Huckell; Sonia Anand; Tom Forbes; Anil Gupta; Ken Harris; Asad Junaid; Tom Lindsay; Finlay McAlister; Andre Roussin; Jacqueline Saw; Koon Kang Teo; Alexander G G Turpie; Subodh Verma
Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary.
The Canadian journal of cardiology 2005;21(12):997-1006.
2005: Alex C Spyropoulos; Alexander G G Turpie
Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation.
Current opinion in pulmonary medicine 2005;11(5):373-9.
2005: Alexander G G Turpie
Multidetector-row computed tomography in suspected pulmonary embolism.
The New England journal of medicine 2005;353(6):630-1; author reply 630-1.
2005: Niranjan Seshadri; Samuel Z Goldhaber; Uri Elkayam; Richard A Grimm; James B Groce; John A Heit; Sarah A Spinler; Alexander G G Turpie; Gideon Bosker; Allan L Klein
The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients.
American heart journal 2005;150(1):27-34.
2005: Alexander G G Turpie
The safety of fondaparinux for the prevention and treatment of venous thromboembolism.
Expert opinion on drug safety 2005;4(4):707-21.
2005: James D Douketis; Jim A Julian; Clive Kearon; David R Anderson; Mark A Crowther; Shannon M Bates; M Barone; Franco Piovella; Alexander G G Turpie; S Middeldorp; Paul van Nguyen; Paolo Prandoni; Philip S Wells; Michael J Kovacs; M R MacGillavry; Lorrie Costantini; Jeffrey S Ginsberg
Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study.
Journal of thrombosis and haemostasis : JTH 2005;3(5):943-8.
2005: Michael J Kovacs; Clive Kearon; Jim A Julian; James D Douketis; Christine Demers; Philip S Wells; Alexander G G Turpie; David R Anderson; Susan R Kahn; Paul V Nguyen; David Green; Jeannine Kassis; William Geerts; Betsy MacKinnon; Jeffrey S Ginsberg
Influence of warfarin on symptoms of fatigue: findings of a randomized trial.
The Annals of pharmacotherapy 2005;39(5):840-2.
2005: Clive Kearon; Jeffrey S Ginsberg; James D Douketis; Mark A Crowther; Alexander G G Turpie; Shannon M Bates; Agnes Lee; Patrick Brill-Edwards; Terri Finch; Michael Gent
A randomized trial of diagnostic strategies after normal proximal vein ultrasonography for suspected deep venous thrombosis: D-dimer testing compared with repeated ultrasonography.
Annals of internal medicine 2005;142(7):490-6.
2005: Nils Kucher; Alain Leizorovicz; Paul T Vaitkus; Alexander T Cohen; Alexander G G Turpie; Carl-Gustav Olsson; Samuel Z Goldhaber
Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial.
Archives of internal medicine 2005;165(3):341-5.
2005: Walter Ageno; Alexander G G Turpie
What's new for DVT prophylaxis for the medically ill.
Disease-a-month : DM 2005;51(2-3):194-9.
2005: Samuel Z Goldhaber; Alexander G G Turpie
Prevention of venous thromboembolism among hospitalized medical patients.
Circulation 2005;111(1):e1-3.
2005: Walter Ageno; Alexander G G Turpie
Clinical trials of deep vein thrombosis prophylaxis in medical patients.
Clinical cornerstone 2005;7(4):16-22.
2005: Alain Leizorovicz; Alexander G G Turpie; Alexander T Cohen; L Wong; M C Yoo; A Dans
Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART study.
Journal of thrombosis and haemostasis : JTH 2005;3(1):28-34.
2005: Paul T Vaitkus; Alain Leizorovicz; Alexander T Cohen; Alexander G G Turpie; Carl-Gustav Olsson; Samuel Z Goldhaber
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients.
Thrombosis and haemostasis 2005;93(1):76-9.
2004: Alexander G G Turpie; Bengt I Eriksson; Kenneth A Bauer; Michael R Lassen
Fondaparinux.
The Journal of the American Academy of Orthopaedic Surgeons 2004;12(6):371-5.
2004: A Y Y Lee; Michael Gent; Jim A Julian; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen; Alexander G G Turpie
Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review.
Journal of thrombosis and haemostasis : JTH 2004;2(10):1752-9.
2004: Michael J Kovacs; Clive Kearon; Marc A Rodger; David R Anderson; Alexander G G Turpie; Shannon M Bates; L Desjardins; James D Douketis; Susan R Kahn; Susan Solymoss; P S Wells
Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Circulation 2004;110(12):1658-63.
2004: Alain Leizorovicz; Alexander T Cohen; Alexander G G Turpie; Carl-Gustav Olsson; Paul T Vaitkus; Samuel Z Goldhaber
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
Circulation 2004;110(7):874-9.
2004: Alexander G G Turpie; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen
Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points.
Chest 2004;126(2):501-8.
2004: Alexander G G Turpie; Timothy M Norris
Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin.
Thrombosis and haemostasis 2004;92(1):3-12.
2004: James D Douketis; Judith A Johnson; Alexander G G Turpie
Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Archives of internal medicine 2004;164(12):1319-26.
2004: Alexander G G Turpie
Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy.
Expert opinion on pharmacotherapy 2004;5(6):1373-84.
2004: Raza Alikhan; Alexander T Cohen; Sophie Combe; Meyer M Samama; Louis Desjardins; Amiram Eldor; Charles Janbon; Alain Leizorovicz; Carl-Gustav Olsson; Alexander G G Turpie
Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.
Archives of internal medicine 2004;164(9):963-8.
2004: Alexander G G Turpie
The design of venous thromboembolism prophylaxis trials: fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery.
International journal of clinical practice 2004;58(5):483-93.
2004: Clive Kearon; Jeffrey S Ginsberg; David R Anderson; Michael J Kovacs; Philip Wells; Jim A Julian; Betsy MacKinnon; Christine Demers; James D Douketis; Alexander G G Turpie; Paul van Nguyen; David Green; Jeannine Kassis; Susan R Kahn; Susan Solymoss; L Desjardins; William Geerts; Marilyn Johnston; Jeffrey I Weitz; Jack Hirsh; Michael Gent
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor.
Journal of thrombosis and haemostasis : JTH 2004;2(5):743-9.
2004: Louis Desjardins; Lucienne Bara; Florent Boutitie; Meyer M Samama; Alexander T Cohen; Sophie Combe; Charles Janbon; Alain Leizorovicz; Carl-Gustav Olsson; Alexander G G Turpie
Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study.
Archives of pathology & laboratory medicine 2004;128(5):519-26.
2004: Walter Ageno; Stefania Crotti; Alexander G G Turpie
The safety of antithrombotic therapy during pregnancy.
Expert opinion on drug safety 2004;3(2):113-8.
2004: Alexander G G Turpie
Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux.
Surgical technology international 2004;13():261-7.
2003: Alexander G G Turpie; Bengt I Eriksson; Kenneth A Bauer; Michael R Lassen
New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies.
Chest 2003;124(6 Suppl):371S-378S.
2003: Alexander G G Turpie
Future therapeutic directions for factor Xa inhibition in the prophylaxis and treatment of thrombotic disorders.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2003;60(22 Suppl 7):S20-4.
2003: Alexander G G Turpie; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
Lancet 2003;362(9395):1582-3.
2003: Alexander G G Turpie; Bengt I Eriksson; Michael R Lassen; Kenneth A Bauer
Fondaparinux, the first selective factor Xa inhibitor.
Current opinion in hematology 2003;10(5):327-32.
2003: Clive Kearon; Jeffrey S Ginsberg; Michael J Kovacs; David R Anderson; Philip Wells; Jim A Julian; Betsy MacKinnon; Jeffrey I Weitz; Mark A Crowther; Sean Dolan; Alexander G G Turpie; William Geerts; Susan Solymoss; Paul van Nguyen; Christine Demers; Susan R Kahn; Jeannine Kassis; Marc A Rodger; Julie Hambleton; Michael Gent
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
The New England journal of medicine 2003;349(7):631-9.
2003: Christopher P Cannon; Alexander G G Turpie
Unstable angina and non-ST-elevation myocardial infarction: initial antithrombotic therapy and early invasive strategy.
Circulation 2003;107(21):2640-5.
2003: Raza Alikhan; Alexander T Cohen; Sophie Combe; Meyer M Samama; Louis Desjardins; Amiram Eldor; Charles Janbon; Alain Leizorovicz; Carl-Gustav Olsson; Alexander G G Turpie
Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(4):341-6.
2003: Andrew S Dunn; Alexander G G Turpie
Perioperative management of patients receiving oral anticoagulants: a systematic review.
Archives of internal medicine 2003;163(8):901-8.
2003: Alexander G G Turpie
Choice of low molecular weight heparins.
Journal of thrombosis and haemostasis : JTH 2003;1(3):598.
2003: B I Eriksson; K A Bauer; M R Lassen; Alexander G G Turpie
Influence of the duration of fondaparinux (Arixtra) prophylaxis in preventing venous thromboembolism following major orthopedic surgery.
Journal of thrombosis and haemostasis : JTH 2003;1(2):383-4.
2002: Walter Ageno; Alexander G G Turpie
Low molecular weight heparins in the treatment of unstable angina.
Minerva cardioangiologica 2002;50(6):643-51.
2002: Ira R A Goldsmith; Alexander G G Turpie; Gregory Y H Lip
Valvar heart disease and prosthetic heart valves.
BMJ (Clinical research ed.) 2002;325(7374):1228-31.
2002: Alexander G G Turpie
Use of selective factor Xa inhibitors in special populations.
American journal of orthopedics (Belle Mead, N.J.) 2002;31(11 Suppl):11-5.
2002: Alexander G G Turpie; Bernard S P Chin; Gregory Y H Lip
ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies.
BMJ (Clinical research ed.) 2002;325(7370):948-50.
2002: Alexander G G Turpie; Bernard S P Chin; Gregory Y H Lip
Venous thromboembolism: pathophysiology, clinical features, and prevention.
BMJ (Clinical research ed.) 2002;325(7369):887-90.
2002: Alexander G G Turpie; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.
Archives of internal medicine 2002;162(16):1833-40.
2002: Walter Ageno; Alexander G G Turpie
Deep venous thrombosis in the medically ill.
Current hematology reports 2002;1(1):73-8.
2002: Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen; Alexander G G Turpie
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism.
Current opinion in pulmonary medicine 2002;8(5):398-404.
2002: Alexander G G Turpie
State of the art--a journey through the world of antithrombotic therapy.
Seminars in thrombosis and hemostasis 2002;28 Suppl 3():3-11.
2002: Alexander G G Turpie
Pentasaccharides.
Seminars in hematology 2002;39(3):158-71.
2002: Alexander G G Turpie; Harry R Büller
Benefit of selective factor inhibition.
Seminars in thrombosis and hemostasis 2002;28 Suppl 2():49-50.
2002: Alexander G G Turpie
Optimizing prophylaxis of venous thromboembolism.
Seminars in thrombosis and hemostasis 2002;28 Suppl 2():25-32.
2002: Alexander G G Turpie; Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.
Lancet 2002;359(9319):1721-6.
2002: Michael Rud Lassen; Kenneth A Bauer; Bengt I Eriksson; Alexander G G Turpie
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.
Lancet 2002;359(9319):1715-20.
2002: Alexander G G Turpie; Jacqueline A Mason
Review of enoxaparin and its clinical applications in venous and arterial thromboembolism.
Expert opinion on pharmacotherapy 2002;3(5):575-98.
2002: Walter Ageno; Alexander G G Turpie
New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;166(7):919-24.
2002: Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen; Alexander G G Turpie
A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialist.
Journal of the Southern Orthopaedic Association 2002;11(4):197-202.
2002: Alexander G G Turpie; Bengt I Eriksson; Michael R Lassen; Kenneth A Bauer
A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.
Journal of the Southern Orthopaedic Association 2002;11(4):182-8.
2001: Kenneth A Bauer; Bengt I Eriksson; Michael R Lassen; Alexander G G Turpie
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
The New England journal of medicine 2001;345(18):1305-10.
2001: Bengt I Eriksson; K A Bauer; Michael R Lassen; Alexander G G Turpie
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
The New England journal of medicine 2001;345(18):1298-304.
2001: Alexander G G Turpie
Setting a standard for venous thromboembolism prophylaxis.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2001;58 Suppl 2():S18-23.
2001: Philip Bath; E Lindenstrom; Gudrun Boysen; Peter Paul De Deyn; Pal Friis; Didier LEYS; Reijo Marttila; J Olsson; Desmond O'Neill; J Orgogozo; Bernd Ringelstein; Jan-Jacob van der Sande; Alexander G G Turpie
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial.
Lancet 2001;358(9283):702-10.
2001: Alexander G G Turpie
Pentasaccharide Org31540/SR90107A clinical trials update: lessons for practice.
American heart journal 2001;142(2 Suppl):S9-15.
2001: Walter Ageno; Alexander G G Turpie; Luigi Steidl; Fabio Ambrosini; R Cattaneo; Romeo Codari; B Nardo; achille venco
Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement.
The American journal of cardiology 2001;88(1):40-4.
2001: E M Holper; Elliott M Antman; Carolyn H McCabe; J Premmereur; Enrique P Gurfinkel; PJ Bernink; Alexander G G Turpie; Antoni Bayes-de-Luna; J M Lablanche; K M Fox; D Salein; David Radley; Eugene Braunwald
A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction.
The American journal of cardiology 2001;87(8):1008-10; A5.
2001: Alexander G G Turpie
Looking forward in the treatment of deep-vein thrombosis.
Seminars in hematology 2001;38(2 Suppl 5):49-57.
2001: Alexander G G Turpie; A S Gallus; J A Hoek
A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.
The New England journal of medicine 2001;344(9):619-25.
2000: Alexander G G Turpie
Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in MEDical patients with ENOXaparin (MEDENOX) trial.
The American journal of cardiology 2000;86(12B):48M-52M.
2000: Marc Cohen; Elliott M Antman; Enrique P Gurfinkel; Alexander G G Turpie; J Furst; Frederique Bigonzi; David Radley
Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction.
The American journal of cardiology 2000;86(5):553-6, A9.
2000: Shaun G Goodman; Marc Cohen; Frederique Bigonzi; Enrique P Gurfinkel; David Radley; V Le Iouer; GJ Fromell; C Demers; Alexander G G Turpie; Robert M Califf; Keith A A Fox; Anatoly Langer
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events.
Journal of the American College of Cardiology 2000;36(3):693-8.
2000: Walter Ageno; J Johnson; B Nowacki; Alexander G G Turpie
A computer generated induction system for hospitalized patients starting on oral anticoagulant therapy.
Thrombosis and haemostasis 2000;83(6):849-52.
2000: Philip S Wells; David R Anderson; Marc A Rodger; Jeffrey S Ginsberg; Clive Kearon; Michael Gent; Alexander G G Turpie; Janis Bormanis; J Weitz; M Chamberlain; D Bowie; D Barnes; Jack Hirsh
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer.
Thrombosis and haemostasis 2000;83(3):416-20.
2000: Walter Ageno; Alexander G G Turpie
Therapy of unstable angina with the low molecular weight heparins.
Vascular medicine (London, England) 2000;5(4):217-23.
2000: Alexander G G Turpie
Antithrombotics and anticoagulants in coronary syndromes and stroke.
Seminars in thrombosis and hemostasis 2000;26 Suppl 1():79-83.
2000: Alexander G G Turpie
Can we differentiate the low-molecular-weight heparins?
Clinical cardiology 2000;23 Suppl 1():I4-7.
1999: Elliott M Antman; Carolyn H McCabe; Enrique P Gurfinkel; Alexander G G Turpie; PJ Bernink; D Salein; Antoni Bayes-de-Luna; K Fox; J M Lablanche; David Radley; J Premmereur; Eugene Braunwald
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.
Circulation 1999;100(15):1593-601.
1999: Meyer M Samama; Alexander T Cohen; J Y Darmon; Louis Desjardins; Amiram Eldor; Charles Janbon; Alain Leizorovicz; H Nguyen; Carl-Gustav Olsson; Alexander G G Turpie; N Weisslinger
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.
The New England journal of medicine 1999;341(11):793-800.
1999: Alexander G G Turpie
Anticoagulants in acute coronary syndromes.
The American journal of cardiology 1999;84(5A):2M-6M.
1999: Alexander G G Turpie
Customizing our approach in deep vein thrombosis and pulmonary embolism treatment: overview of our clinical experience.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10 Suppl 2():S107-15.
1999: Clive Kearon; Michael Gent; Jack Hirsh; Jeffrey Weitz; Michael J Kovacs; David R Anderson; Alexander G G Turpie; David Green; Jeffrey S Ginsberg; Philip Wells; Betsy MacKinnon; Jim A Julian
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
The New England journal of medicine 1999;340(12):901-7.
1998: Philip S Wells; Jeffrey S Ginsberg; David R Anderson; Clive Kearon; Michael Gent; Alexander G G Turpie; Janis Bormanis; J Weitz; M Chamberlain; D Bowie; D Barnes; Jack Hirsh
Use of a clinical model for safe management of patients with suspected pulmonary embolism.
Annals of internal medicine 1998;129(12):997-1005.
1998: Jeffrey S Ginsberg; Philip S Wells; Clive Kearon; D Anderson; Mark Crowther; Jeffrey I Weitz; Janis Bormanis; Patrick Brill-Edwards; Alexander G G Turpie; Betsy MacKinnon; Michael Gent; Jack Hirsh
Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism.
Annals of internal medicine 1998;129(12):1006-11.
1998: Alexander G G Turpie; A Kher
Prevention of venous thrombosis after elective hip surgery.
Orthopedics 1998;21(12):1275-81.
1998: Marc Cohen; C Demers; Enrique P Gurfinkel; Alexander G G Turpie; GJ Fromell; S Goodman; Anatoly Langer; Robert M Califf; Keith A A Fox; J Premmereur; Frederique Bigonzi
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.
The American journal of cardiology 1998;82(5B):19L-24L.
1998: Walter Ageno; Alexander G G Turpie
A randomized comparison of a computer-based dosing program with a manual system to monitor oral anticoagulant therapy.
Thrombosis research 1998;91(5):237-40.
1998: Alexander G G Turpie
Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B.
The Canadian journal of cardiology 1998;14 Suppl E():20E-23E.
1998: Alexander G G Turpie
Pharmacology of the low-molecular-weight heparins.
American heart journal 1998;135(6 Pt 3 Su):S329-35.
1998: Daniel B Mark; Patricia A Cowper; Scott Darrell Berkowitz; Linda Davidson-Ray; Elizabeth R DeLong; Alexander G G Turpie; Robert M Califf; Beth D Weatherley; Marc Cohen
Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction].
Circulation 1998;97(17):1702-7.
1997: Joel G Ray; Alexander G G Turpie
Survey of cardiac surgeons' perceptions of the addition of ASA to warfarin for patients with mechanical heart valves.
The Canadian journal of cardiology 1997;13(12):1162-5.
1997: Alexander G G Turpie
Successors to heparin: new antithrombotic agents.
American heart journal 1997;134(5 Pt 2):S71-7.
1997: Alexander G G Turpie
New frontiers in the management of unstable coronary artery disease.
The American journal of cardiology 1997;80(5A):21E-24E.
1997: Marc Cohen; C Demers; Enrique P Gurfinkel; Alexander G G Turpie; GJ Fromell; S Goodman; Anatoly Langer; Robert M Califf; Keith A A Fox; J Premmereur; Frederique Bigonzi
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
The New England journal of medicine 1997;337(7):447-52.
1997: Alexander G G Turpie
Antithrombotic therapy following heart valve replacement.
Thrombosis and haemostasis 1997;78(1):382-5.
1997: Jeffrey S Ginsberg; Clive Kearon; James D Douketis; Alexander G G Turpie; Patrick Brill-Edwards; P Stevens; Akbar Panju; A Patel; Mark Crowther; Maureen Andrew; Patricia Massicotte; Jack Hirsh; Jeffrey I Weitz
The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis.
Archives of internal medicine 1997;157(10):1077-81.
1997: Alexander G G Turpie
Low-molecular-weight heparin: from the bench to the orthopedic patient.
Orthopedics 1997;20 Suppl():10-3.
1997: Alexander G G Turpie
Prophylaxis of venous thromboembolism in stroke patients.
Seminars in thrombosis and hemostasis 1997;23(2):155-7.
1996: Mark N Levine; M Gent; J Hirsh; Jeffrey Weitz; Alexander G G Turpie; P Powers; J Neemeh; Andrew R Willan; P Skingley
Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery.
Archives of internal medicine 1996;156(8):851-6.
1996: Mark Levine; M Gent; J Hirsh; J Leclerc; D Anderson; Jeffrey Weitz; J Ginsberg; Alexander G G Turpie; C Demers; M Kovacs
A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.
The New England journal of medicine 1996;334(11):677-81.
1996: M Gent; J Hirsh; J S Ginsberg; P J Powers; Mark N Levine; W H Geerts; R M Jay; J Leclerc; J A Neemeh; Alexander G G Turpie
Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture.
Circulation 1996;93(1):80-4.
1995: Mark N Levine; J Hirsh; M Gent; Alexander G G Turpie; Jeffrey Weitz; Jeffrey Ginsberg; W Geerts; J LeClerc; J Neemeh; P Powers
Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
Thrombosis and haemostasis 1995;74(2):606-11.
1995: Alexander G G Turpie; Jeffrey I Weitz; J Hirsh
Advances in antithrombotic therapy: novel agents.
Thrombosis and haemostasis 1995;74(1):565-71.
1995: Alexander G G Turpie
Deep vein thrombosis prophylaxis in the outpatient setting: preventing complications following hospital discharge.
Orthopedics 1995;18 Suppl():15-7.
1994: Mark N Levine; J Hirsh; M Gent; Alexander G G Turpie; M Cruickshank; Jeffrey Weitz; D Anderson; M Johnson
A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
Archives of internal medicine 1994;154(1):49-56.
1993: Alexander G G Turpie; M Gent; A Laupacis; Y Latour; J Gunstensen; F Basile; M Klimek; J Hirsh
A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.
The New England journal of medicine 1993;329(8):524-9.
1992: Alexander G G Turpie; M Gent; R Côte; Mark N Levine; J S Ginsberg; P J Powers; J Leclerc; W Geerts; R Jay; J Neemeh
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.
Annals of internal medicine 1992;117(5):353-7.
1992: Alexander G G Turpie
Orgaran in the prevention of deep vein thrombosis in stroke patients.
Haemostasis 1992;22(2):92-8.
1991: Alexander G G Turpie
Efficacy of a postoperative regimen of enoxaparin in deep vein thrombosis prophylaxis.
American journal of surgery 1991;161(4):532-6.
1991: Mark N Levine; J Hirsh; M Gent; Alexander G G Turpie; J Leclerc; P J Powers; R M Jay; J Neemeh
Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
Annals of internal medicine 1991;114(7):545-51.
1990: M Levine; J Hirsh; Jeffrey Weitz; M Cruickshank; J Neemeh; Alexander G G Turpie; M Gent
A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
Chest 1990;98(6):1473-9.
1990: Alexander G G Turpie; Mark N Levine; J Hirsh; J S Ginsberg; M Cruickshank; R Jay; M Gent
Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.
Chest 1990;97(4 Suppl):172S-175S.
1990: Mark N Levine; Jeffrey Weitz; Alexander G G Turpie; Maureen Andrew; M Cruickshank; J Hirsh
A new short infusion dosage regimen of recombinant tissue plasminogen activator in patients with venous thromboembolic disease.
Chest 1990;97(4 Suppl):168S-171S.
1990: Alexander G G Turpie
Anticoagulant therapy after acute myocardial infarction.
The American journal of cardiology 1990;65(6):20C-23C.
1990: Alexander G G Turpie
Enoxaparin prophylaxis in elective hip surgery.
Acta chirurgica Scandinavica. Supplementum 1990;556():103-7.
1989: Alexander G G Turpie
Therapy of deep vein thrombosis.
Herz 1989;14(6):341-7.
1989: M K Cruickshank; Mark N Levine; J Hirsh; Alexander G G Turpie; P Powers; R Jay; M Gent
An evaluation of impedance plethysmography and 125I-fibrinogen leg scanning in patients following hip surgery.
Thrombosis and haemostasis 1989;62(3):830-4.
1989: J S Ginsberg; A Shin; Alexander G G Turpie; J Hirsh
Detection of previous proximal venous thrombosis with Doppler ultrasonography and photoplethysmography.
Archives of internal medicine 1989;149(10):2255-7.
1989: M Gent; J A Blakely; J D Easton; D J Ellis; vladimir hachinski; J W Harbison; E Panak; R S Roberts; J Sicurella; Alexander G G Turpie
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.
Lancet 1989;1(8649):1215-20.
1989: P J Powers; M Gent; R M Jay; D H Julian; Alexander G G Turpie; Mark Levine; J Hirsh
A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip.
Archives of internal medicine 1989;149(4):771-4.
1989: Alexander G G Turpie; J Hirsh; M Gent; D Julian; J Johnson
Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control.
Archives of internal medicine 1989;149(3):679-81.
1989: Alexander G G Turpie; J G Robinson; D J Doyle; A S Mulji; G J Mishkel; B J Sealey; John A Cairns; L Skingley; J Hirsh; M Gent
Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction.
The New England journal of medicine 1989;320(6):352-7.
1989: Alexander G G Turpie; R Bloch; R Duke
Heparin in the treatment of thromboembolic stroke.
Annals of the New York Academy of Sciences 1989;556():406-15.
1988: M Gent; J A Blakely; J D Easton; D J Ellis; vladimir hachinski; J W Harbison; E Panak; R S Roberts; J Sicurella; Alexander G G Turpie
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline results.
Stroke; a journal of cerebral circulation 1988;19(10):1203-10.
1988: Alexander G G Turpie
Clinical studies: evidence for intervention with specific antiplatelet drugs in arterial thromboembolism.
Seminars in thrombosis and hemostasis 1988;14(1):41-9.
1988: Alexander G G Turpie
Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke.
Acta chirurgica Scandinavica. Supplementum 1988;543():85-6.
1987: Alexander G G Turpie; Mark N Levine; J Hirsh; C J Carter; R M Jay; P J Powers; M Andrew; H N Magnani; R D Hull; M Gent
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke.
Lancet 1987;1(8532):523-6.
1986: Alexander G G Turpie; Mark N Levine; J Hirsh; C J Carter; R M Jay; P J Powers; M Andrew; Russell D Hull; M Gent
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.
The New England journal of medicine 1986;315(15):925-9.
1985: Russell D Hull; J Hirsh; C J Carter; R M Jay; P A Ockelford; H R Buller; Alexander G G Turpie; P Powers; D Kinch; P E Dodd
Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trial.
Annals of internal medicine 1985;102(1):21-8.
1983: Russell D Hull; J Hirsh; C J Carter; R M Jay; P E Dodd; P A Ockelford; G Coates; G J Gill; Alexander G G Turpie; D J Doyle; H R Buller; Gary E Raskob
Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan.
Annals of internal medicine 1983;98(6):891-9.
1983: Russell D Hull; C J Carter; R M Jay; P A Ockelford; J Hirsch; Alexander G G Turpie; A Zielinsky; M Gent; P J Powers
The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge.
Circulation 1983;67(4):901-6.
1982: A Zielinsky; J Hirsh; G Straumanis; C J Carter; M Gent; D L Sackett; R Hull; J G Kelton; P Powers; Alexander G G Turpie
The diagnostic value of the fibrinogen/fibrin fragment E antigen assay in clinically suspected deep vein thrombosis.
Blood 1982;59(2):346-50.
1981: R Hull; J Hirsh; D L Sackett; D W Taylor; C Carter; Alexander G G Turpie; A Zielinsky; P Powers; M Gent
Replacement of venography in suspected venous thrombosis by impedance plethysmography and 125I-fibrinogen leg scanning: a less invasive approach.
Annals of internal medicine 1981;94(1):12-5.